The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Grigorian O.R.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia Rossii, Moskva

Andreeva E.N.

Mediko-geneticheskoe otdelenie Moskovskogo oblastnogo NII akusherstva i ginekologii

The influence of  oral combined oral contraceptive with estradiol valerate and dienogest  on hemostatic system (a review)

Authors:

Grigorian O.R., Andreeva E.N.

More about the authors

Journal: Russian Journal of Human Reproduction. 2015;21(2): 14‑17

DOI: 10.17116/repro201521214-17

Read: 16216 times

Download PDF (RU)
Contact the author
Table of contents

THE INFLUENCE OF ORAL COMBINED ORAL CONTRACEPTIVE WITH ESTRADIOL VALERATE AND DIENOGEST  ON HEMOSTATIC SYSTEM (A REVIEW)
THE INFLUENCE OF ORAL COMBINED ORAL CONTRACEPTIVE WITH ESTRADIOL VALERATE AND DIENOGEST  ON HEMOSTATIC SYSTEM (A REVIEW)

To cite this article:

Grigorian OR, Andreeva EN. The influence of  oral combined oral contraceptive with estradiol valerate and dienogest  on hemostatic system (a review). Russian Journal of Human Reproduction. 2015;21(2):14‑17. (In Russ.)
https://doi.org/10.17116/repro201521214-17

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Pulmonary distress syndrome in urgent surgery: A concept, pathogenesis, and fundamentals of treatment. Piro­gov Russian Journal of Surgery. 2025;(2):77-85
Hemo­stasis diso­rders during neoadjuvant therapy in patients with breast cancer. P.A. Herzen Journal of Onco­logy. 2025;(3):39-44
Abstract:

Estrogens and progestins as the part of COCs have a complex mechanism of action on hemostasis. The drug containing estradiol valerate and dienogest has no thrombophilic effect on platelet procoagulant and hemostasis.

Keywords:

hemostasis
estradiol valerate
D-dimer
fibrinolysis

Authors:

Grigorian O.R.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia Rossii, Moskva

Andreeva E.N.

Mediko-geneticheskoe otdelenie Moskovskogo oblastnogo NII akusherstva i ginekologii

Close metadata

References:

  1. Ahrendt HJ, Makalova D, Parke S. et al. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Contraception. 2009; 80: 5: 436-444. 
  2. Blickstein I. Thrombophilia and women’s health: an overview. Obstet Gynecol Clin North Am. 2006;33:3:347-356. 
  3. Klipping C, Duijkers I, Parke S, Mellinger U, Serrani M, Junge W. Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive. Drugs. 2011;11:2:159-170. 
  4. Helgason S. Estrogen replacement therapy after the menopause: estrogenicity and metabolic effects. Acta Obstet Gynecol Scand Suppl. 1982;107:1-29. 
  5. Kluft C, Endrikat J, Mulder SM. et al. A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol. Contraception. 2006;73:4:336-343.
  6. Lindberg UB, Crona N, Stigendal L. et al. A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters. Thromb Haemost. 1989;61:1:65-69.
  7. Lowe GD. Common risk factors for both arterial and venous thrombosis. Br J Haematol. 2008;140:5:488-495.
  8. Lu M, Uddin A, Foegh M. et al. Pharmacokinetics and pharmacodynamics of a new four-phasic estradiol valerate and dienogest oral contraceptive [abstract]. Obstet Gynecol. 2007;109:4:Suppl:61S.
  9. Mashchak CA, Lobo RA, Dozono-Takano R. et al. Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol. 1982;144:5:511-518. 
  10. Rosing J, Tans G, Nicolaes GA. et al. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. Br J Haematol. 1997;97:1:233-238.
  11. Wiegratz I, Lee JH, Kutschera E. et al. Effect of four oral contraceptives on hemostatic parameters. Contraception. 2004;70:2:97-106. 
  12. Linnikov V.I., Bondarenko N.I. Vliyanie oral'nykh kontratseptivov na sistemu gemostaza i metabolizm lipidov. Tavricheskii mediko-biologicheskii vestnik. 2011;14:3:1:55: 141-143.
  13. Nappi RE, Serrani M, Jensen JT. Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature. Int J Womens Health. 2014; 6: 711-718.
  14. Macìas G, Merki-Feld GS, Parke S, Mellinger U, Serrani M. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study. J Obstet Gynaecol. 2013;33:6:591-596. 
  15. Arabadzhi O.A. Sostoyanie gemostaza i uroven' gomotsisteina u zhenshchin na fone priema sinteticheskikh progestinov s kontratseptivnoi i lechebnoi tsel'yu: Dis. ... kand. med. nauk. Tomsk 2014.
  16. Nelson A, Parke S, Makalova D, Serrani M, Palacios S, Mellinger U. Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe. Eur J Contracept Reprod Health Care. 2013;18:4:264-273. 
  17. Raps M, Rosendaal F, Ballieux B, Rosing J, Thomassen S, Helmerhorst F, van Vliet H. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial. J Thromb Haemost. 2013;11:5:855-861. 
  18. Zakhurdaeva L.D. Estrogeny: biologicheskie i farmakologicheskie effekty. Meditsinskie aspekty zdorov'ya zhenshchiny. 2010;7:35.
  19. Andreeva E.N., Karpova E.A., Ponomareva T.A. Novye vozmozhnosti gestagenov: drospirenon — progestagen s antimineralokortikoidnymi svoistvami. Rossiiskii vestnik akushera-ginekologa. 2004;4:6:26-29.
  20. Endrikat J, Parke S, Trummer D. et al. Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: Results of two prospective, randomized, open-label studies. Contraception. 2008;78:3:218-225.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.